EClinMed (2021) 42:101213
It's available under brand names such as Wegovy, specifically for weight management, and Ozempic for type 2 diabetes management
None asked for proof of BMI, nor did any require that I also show evidence of at least one weight-related ailment, even though the official recommendation for prescribing this type of medication to a person with a BMI of 27 is the presence of one such ailment
Semaglutide (the generic name for Wegovy) is a part of the GLP-1 receptor agonists, which marked a major advancement in the class of drugs used to treat type 2 diabetes
Post-marketing surveillance and pharmacovigilance databases occasionally report seizure events in patients using weight loss medications, but establishing causality versus coincidental occurrence remains challenging
Face and neck changes often appear first, followed by reduced waist circumference and improved muscle definition